DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,088 filers reported holding DANAHER CORPORATION in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,300 | +1.9% | 17,333 | -1.4% | 1.76% | +5.7% |
| Q2 2023 | $4,218 | -5.8% | 17,577 | -1.1% | 1.67% | -12.7% |
| Q1 2023 | $4,480 | -5.6% | 17,775 | -0.6% | 1.91% | -11.5% |
| Q4 2022 | $4,746 | -99.9% | 17,879 | -6.8% | 2.16% | -8.5% |
| Q3 2022 | $4,955,000 | +0.8% | 19,183 | -1.0% | 2.36% | +6.8% |
| Q2 2022 | $4,914,000 | -14.5% | 19,382 | -1.1% | 2.21% | +3.2% |
| Q1 2022 | $5,748,000 | -18.3% | 19,596 | -8.3% | 2.14% | -8.2% |
| Q4 2021 | $7,034,000 | +7.2% | 21,380 | -0.8% | 2.33% | 0.0% |
| Q3 2021 | $6,564,000 | +11.2% | 21,560 | -2.0% | 2.33% | +13.7% |
| Q2 2021 | $5,904,000 | +45.1% | 21,999 | +21.7% | 2.05% | +16.0% |
| Q1 2021 | $4,069,000 | +1.2% | 18,079 | -0.1% | 1.77% | -7.1% |
| Q4 2020 | $4,022,000 | +2.3% | 18,104 | -0.8% | 1.90% | -11.1% |
| Q3 2020 | $3,931,000 | +19.8% | 18,254 | -1.6% | 2.14% | +12.7% |
| Q2 2020 | $3,281,000 | +14.4% | 18,554 | -10.5% | 1.90% | -1.6% |
| Q1 2020 | $2,868,000 | -10.3% | 20,720 | -0.5% | 1.93% | +21.0% |
| Q4 2019 | $3,196,000 | -27.2% | 20,825 | -31.5% | 1.60% | -22.3% |
| Q3 2019 | $4,391,000 | +1.0% | 30,399 | -0.0% | 2.05% | +4.6% |
| Q2 2019 | $4,346,000 | +8.2% | 30,409 | -0.1% | 1.96% | +4.9% |
| Q1 2019 | $4,018,000 | +27.2% | 30,434 | -0.7% | 1.87% | +11.8% |
| Q4 2018 | $3,159,000 | -6.4% | 30,634 | -1.4% | 1.68% | +10.6% |
| Q3 2018 | $3,375,000 | +9.9% | 31,059 | -0.2% | 1.52% | +2.5% |
| Q2 2018 | $3,070,000 | -3.0% | 31,109 | -3.8% | 1.48% | -3.1% |
| Q1 2018 | $3,166,000 | +2.3% | 32,339 | -3.0% | 1.53% | +3.0% |
| Q4 2017 | $3,096,000 | +0.8% | 33,354 | -6.9% | 1.48% | +2.3% |
| Q3 2017 | $3,072,000 | -4.9% | 35,814 | -6.4% | 1.45% | -5.4% |
| Q2 2017 | $3,229,000 | -8.0% | 38,259 | -6.8% | 1.53% | -8.3% |
| Q1 2017 | $3,510,000 | 0.0% | 41,044 | -9.0% | 1.67% | +4.6% |
| Q4 2016 | $3,510,000 | -5.7% | 45,094 | -5.1% | 1.60% | -5.1% |
| Q3 2016 | $3,723,000 | -25.6% | 47,494 | -4.1% | 1.68% | -27.5% |
| Q2 2016 | $5,001,000 | +6.2% | 49,519 | -0.2% | 2.32% | +6.3% |
| Q1 2016 | $4,707,000 | -0.1% | 49,619 | -2.2% | 2.18% | +8.1% |
| Q4 2015 | $4,714,000 | -3.3% | 50,754 | -11.2% | 2.02% | +12.6% |
| Q3 2015 | $4,873,000 | -0.6% | 57,187 | -0.2% | 1.79% | +13.5% |
| Q2 2015 | $4,903,000 | +2.6% | 57,287 | +1.8% | 1.58% | +0.7% |
| Q1 2015 | $4,778,000 | -1.3% | 56,282 | -0.3% | 1.57% | -5.5% |
| Q4 2014 | $4,840,000 | +25.2% | 56,472 | +11.0% | 1.66% | +4.5% |
| Q3 2014 | $3,866,000 | -11.1% | 50,877 | -7.9% | 1.59% | -4.8% |
| Q2 2014 | $4,348,000 | +15.1% | 55,222 | +9.6% | 1.67% | +0.1% |
| Q1 2014 | $3,778,000 | -2.7% | 50,372 | +0.1% | 1.66% | -6.7% |
| Q4 2013 | $3,883,000 | +4.7% | 50,297 | 0.0% | 1.78% | -0.9% |
| Q3 2013 | $3,710,000 | – | 50,297 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |